Concepts (241)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 14 | 2021 | 91 | 4.490 |
Why?
|
| Calcium | 15 | 2018 | 445 | 2.710 |
Why?
|
| Presynaptic Terminals | 9 | 2014 | 52 | 2.440 |
Why?
|
| Peptide Fragments | 7 | 2021 | 298 | 2.330 |
Why?
|
| Neurons | 10 | 2021 | 1130 | 1.370 |
Why?
|
| Neuroprotective Agents | 3 | 2020 | 231 | 1.260 |
Why?
|
| Alzheimer Disease | 6 | 2023 | 881 | 1.190 |
Why?
|
| Animals | 39 | 2023 | 14307 | 0.980 |
Why?
|
| Hippocampus | 7 | 2021 | 546 | 0.900 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 4 | 2011 | 7 | 0.880 |
Why?
|
| Mice | 22 | 2023 | 5668 | 0.820 |
Why?
|
| Neuronal Plasticity | 3 | 2018 | 102 | 0.780 |
Why?
|
| Homeostasis | 4 | 2020 | 172 | 0.770 |
Why?
|
| Nicotine | 8 | 2011 | 238 | 0.750 |
Why?
|
| Synaptosomes | 6 | 2011 | 21 | 0.730 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 5 | 2018 | 58 | 0.680 |
Why?
|
| Drug Discovery | 1 | 2019 | 77 | 0.660 |
Why?
|
| Fear | 3 | 2017 | 234 | 0.640 |
Why?
|
| Molecular Probes | 1 | 2016 | 23 | 0.590 |
Why?
|
| Amyloid beta-Protein Precursor | 2 | 2020 | 95 | 0.580 |
Why?
|
| Microglia | 3 | 2023 | 152 | 0.570 |
Why?
|
| Mice, Transgenic | 5 | 2023 | 608 | 0.540 |
Why?
|
| Pharmaceutical Preparations | 1 | 2016 | 74 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 13 | 2021 | 1530 | 0.520 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 162 | 0.510 |
Why?
|
| Calcium Channels | 2 | 2007 | 72 | 0.490 |
Why?
|
| Neostriatum | 2 | 2006 | 25 | 0.480 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2021 | 45 | 0.450 |
Why?
|
| Liver | 5 | 2021 | 447 | 0.450 |
Why?
|
| Synapses | 3 | 2019 | 173 | 0.420 |
Why?
|
| Purkinje Cells | 1 | 2011 | 19 | 0.420 |
Why?
|
| Amino Acids, Aromatic | 1 | 2011 | 5 | 0.420 |
Why?
|
| Cerebellum | 1 | 2011 | 69 | 0.410 |
Why?
|
| Amyloid | 1 | 2011 | 52 | 0.400 |
Why?
|
| Receptors, Serotonin | 2 | 2001 | 21 | 0.390 |
Why?
|
| Cerebral Cortex | 2 | 2009 | 274 | 0.370 |
Why?
|
| Male | 23 | 2021 | 18870 | 0.370 |
Why?
|
| Membrane Microdomains | 1 | 2010 | 46 | 0.370 |
Why?
|
| Dopamine | 2 | 2011 | 232 | 0.370 |
Why?
|
| Schools, Medical | 3 | 2018 | 192 | 0.360 |
Why?
|
| Models, Biological | 1 | 2013 | 642 | 0.360 |
Why?
|
| Receptors, Presynaptic | 2 | 2006 | 4 | 0.350 |
Why?
|
| Reactive Oxygen Species | 3 | 2017 | 416 | 0.340 |
Why?
|
| Cell Line, Tumor | 4 | 2017 | 2128 | 0.340 |
Why?
|
| Microscopy, Confocal | 5 | 2010 | 210 | 0.330 |
Why?
|
| TRPC Cation Channels | 1 | 2007 | 7 | 0.320 |
Why?
|
| Corpus Striatum | 3 | 2009 | 99 | 0.320 |
Why?
|
| GTP-Binding Proteins | 2 | 2018 | 57 | 0.320 |
Why?
|
| Benzofurans | 3 | 2021 | 19 | 0.320 |
Why?
|
| Mice, Knockout | 6 | 2021 | 897 | 0.310 |
Why?
|
| Inflammation | 2 | 2023 | 577 | 0.310 |
Why?
|
| Adenosine Triphosphatases | 1 | 2007 | 78 | 0.300 |
Why?
|
| tau Proteins | 2 | 2020 | 161 | 0.300 |
Why?
|
| Rats | 9 | 2011 | 3261 | 0.290 |
Why?
|
| Neocortex | 2 | 2003 | 26 | 0.290 |
Why?
|
| Nicotinic Agonists | 4 | 2009 | 68 | 0.290 |
Why?
|
| Cell Line | 3 | 2020 | 1289 | 0.280 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2006 | 35 | 0.280 |
Why?
|
| Prefrontal Cortex | 1 | 2007 | 133 | 0.280 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2006 | 68 | 0.280 |
Why?
|
| Signal Transduction | 5 | 2019 | 1802 | 0.270 |
Why?
|
| Gossypium | 3 | 2021 | 5 | 0.270 |
Why?
|
| Molecular Biology | 2 | 2015 | 44 | 0.250 |
Why?
|
| Luteolin | 2 | 2021 | 9 | 0.250 |
Why?
|
| Metabolomics | 4 | 2020 | 76 | 0.250 |
Why?
|
| Bungarotoxins | 4 | 2011 | 21 | 0.240 |
Why?
|
| Humans | 12 | 2023 | 34853 | 0.240 |
Why?
|
| Gliosis | 1 | 2023 | 22 | 0.230 |
Why?
|
| Neuroblastoma | 2 | 2001 | 128 | 0.230 |
Why?
|
| Bile Acids and Salts | 3 | 2018 | 31 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 5 | 2009 | 1534 | 0.230 |
Why?
|
| Disease Models, Animal | 3 | 2023 | 1300 | 0.220 |
Why?
|
| Oxidative Stress | 3 | 2017 | 874 | 0.210 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 2 | 2018 | 9 | 0.210 |
Why?
|
| Plant Diseases | 2 | 2019 | 52 | 0.200 |
Why?
|
| Lipogenesis | 1 | 2021 | 18 | 0.200 |
Why?
|
| Nematode Infections | 1 | 2021 | 1 | 0.200 |
Why?
|
| Tylenchoidea | 1 | 2021 | 3 | 0.200 |
Why?
|
| Synaptic Transmission | 2 | 2018 | 141 | 0.200 |
Why?
|
| Synaptic Potentials | 1 | 2021 | 7 | 0.200 |
Why?
|
| Ceramides | 1 | 2021 | 41 | 0.200 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2000 | 5 | 0.200 |
Why?
|
| Nerve Endings | 1 | 2000 | 8 | 0.200 |
Why?
|
| Presenilin-1 | 1 | 2020 | 27 | 0.190 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 79 | 0.190 |
Why?
|
| Biguanides | 3 | 2009 | 7 | 0.190 |
Why?
|
| Lipopolysaccharides | 1 | 2021 | 200 | 0.190 |
Why?
|
| Axons | 1 | 2001 | 106 | 0.190 |
Why?
|
| Alkanesulfonic Acids | 1 | 2020 | 7 | 0.190 |
Why?
|
| Memory Disorders | 1 | 2020 | 65 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2020 | 117 | 0.180 |
Why?
|
| Gene Expression Regulation | 3 | 2021 | 968 | 0.180 |
Why?
|
| Mitochondria | 2 | 2017 | 454 | 0.180 |
Why?
|
| Fluorocarbons | 1 | 2020 | 19 | 0.180 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 859 | 0.180 |
Why?
|
| Xanthomonas | 1 | 2019 | 2 | 0.170 |
Why?
|
| Microbiological Techniques | 1 | 2019 | 11 | 0.170 |
Why?
|
| Fusarium | 1 | 2018 | 7 | 0.170 |
Why?
|
| Berberine | 1 | 2018 | 5 | 0.170 |
Why?
|
| Disease Management | 1 | 2019 | 61 | 0.170 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 92 | 0.170 |
Why?
|
| DNA Repair | 1 | 2020 | 181 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 430 | 0.170 |
Why?
|
| Nicotinic Antagonists | 3 | 2011 | 28 | 0.160 |
Why?
|
| Vitamin A Deficiency | 1 | 2017 | 14 | 0.160 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 115 | 0.160 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2017 | 71 | 0.160 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2018 | 73 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2018 | 69 | 0.160 |
Why?
|
| Conditioning, Operant | 1 | 2017 | 72 | 0.150 |
Why?
|
| Oligopeptides | 1 | 2017 | 97 | 0.150 |
Why?
|
| Calcium Signaling | 1 | 2018 | 95 | 0.150 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2011 | 70 | 0.150 |
Why?
|
| Disease Progression | 1 | 2019 | 580 | 0.150 |
Why?
|
| Cell Death | 1 | 2017 | 260 | 0.150 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 180 | 0.140 |
Why?
|
| Energy Metabolism | 1 | 2017 | 160 | 0.140 |
Why?
|
| Lipid Metabolism | 4 | 2020 | 109 | 0.140 |
Why?
|
| Molecular Structure | 1 | 2017 | 467 | 0.140 |
Why?
|
| Environmental Pollutants | 2 | 2015 | 166 | 0.140 |
Why?
|
| MicroRNAs | 1 | 2021 | 386 | 0.140 |
Why?
|
| Curriculum | 1 | 2018 | 237 | 0.140 |
Why?
|
| Ileum | 1 | 2014 | 15 | 0.130 |
Why?
|
| Cell Biology | 1 | 2014 | 11 | 0.130 |
Why?
|
| Organ Culture Techniques | 1 | 2014 | 99 | 0.130 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 59 | 0.130 |
Why?
|
| Cecum | 3 | 2020 | 16 | 0.120 |
Why?
|
| Research | 1 | 2015 | 159 | 0.120 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2020 | 165 | 0.110 |
Why?
|
| Sensory Gating | 1 | 2012 | 6 | 0.110 |
Why?
|
| Parvalbumins | 1 | 2012 | 15 | 0.110 |
Why?
|
| Universities | 1 | 2015 | 363 | 0.110 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 1124 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2021 | 1442 | 0.100 |
Why?
|
| Peptide Mapping | 1 | 2011 | 19 | 0.100 |
Why?
|
| Interneurons | 1 | 2012 | 53 | 0.100 |
Why?
|
| Aged | 1 | 2023 | 6448 | 0.100 |
Why?
|
| Selenoprotein P | 1 | 2012 | 50 | 0.100 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1490 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2012 | 156 | 0.100 |
Why?
|
| Drug Interactions | 2 | 2011 | 137 | 0.100 |
Why?
|
| Hybrid Cells | 2 | 2001 | 19 | 0.100 |
Why?
|
| Female | 5 | 2020 | 19873 | 0.100 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 984 | 0.100 |
Why?
|
| Mutation, Missense | 1 | 2011 | 80 | 0.100 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 168 | 0.100 |
Why?
|
| Ventral Tegmental Area | 1 | 2011 | 36 | 0.100 |
Why?
|
| Apoptosis | 1 | 2017 | 1317 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 383 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 480 | 0.090 |
Why?
|
| Evoked Potentials | 1 | 2010 | 83 | 0.090 |
Why?
|
| Microdialysis | 1 | 2007 | 18 | 0.080 |
Why?
|
| Protein Subunits | 1 | 2007 | 85 | 0.080 |
Why?
|
| Dihydro-beta-Erythroidine | 2 | 2011 | 4 | 0.080 |
Why?
|
| Magnesium | 1 | 2007 | 95 | 0.080 |
Why?
|
| Veratridine | 1 | 2006 | 1 | 0.070 |
Why?
|
| Quinpirole | 1 | 2006 | 16 | 0.070 |
Why?
|
| Dopamine Antagonists | 1 | 2006 | 39 | 0.070 |
Why?
|
| Dopamine Agonists | 1 | 2006 | 29 | 0.070 |
Why?
|
| Neurotransmitter Agents | 1 | 2006 | 57 | 0.070 |
Why?
|
| Sodium Channels | 1 | 2006 | 63 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2007 | 528 | 0.070 |
Why?
|
| Hawaii | 3 | 2018 | 1878 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2007 | 490 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2017 | 281 | 0.070 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2002 | 4 | 0.060 |
Why?
|
| Acetates | 1 | 2002 | 20 | 0.060 |
Why?
|
| Anticonvulsants | 1 | 2002 | 34 | 0.050 |
Why?
|
| Calcium Channel Blockers | 1 | 2002 | 56 | 0.050 |
Why?
|
| Amines | 1 | 2002 | 38 | 0.050 |
Why?
|
| Gene Expression | 2 | 2015 | 639 | 0.050 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2021 | 3 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2021 | 91 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2021 | 9 | 0.050 |
Why?
|
| Animal Experimentation | 1 | 2021 | 2 | 0.050 |
Why?
|
| Diet | 2 | 2020 | 747 | 0.050 |
Why?
|
| Potassium Chloride | 1 | 2001 | 25 | 0.050 |
Why?
|
| Culture Media, Conditioned | 1 | 2001 | 44 | 0.050 |
Why?
|
| Bradykinin | 1 | 2000 | 22 | 0.050 |
Why?
|
| Triglycerides | 1 | 2021 | 129 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2000 | 51 | 0.050 |
Why?
|
| Caffeine | 1 | 2000 | 26 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2001 | 96 | 0.050 |
Why?
|
| Gene Expression Regulation, Plant | 1 | 2021 | 58 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2001 | 60 | 0.050 |
Why?
|
| Long-Term Potentiation | 1 | 2021 | 99 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2000 | 177 | 0.050 |
Why?
|
| Potassium | 1 | 2000 | 110 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2000 | 213 | 0.050 |
Why?
|
| Glioma | 1 | 2000 | 76 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2000 | 123 | 0.050 |
Why?
|
| Metabolome | 1 | 2020 | 47 | 0.050 |
Why?
|
| Kinetics | 1 | 2001 | 650 | 0.040 |
Why?
|
| Taurocholic Acid | 1 | 2018 | 7 | 0.040 |
Why?
|
| Clostridium | 1 | 2018 | 19 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2021 | 306 | 0.040 |
Why?
|
| Amidohydrolases | 1 | 2018 | 10 | 0.040 |
Why?
|
| Gossypol | 1 | 2018 | 5 | 0.040 |
Why?
|
| Seeds | 1 | 2019 | 34 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 2018 | 30 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2000 | 257 | 0.040 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2018 | 9 | 0.040 |
Why?
|
| Plant Leaves | 1 | 2019 | 110 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 834 | 0.040 |
Why?
|
| Random Allocation | 1 | 2018 | 139 | 0.040 |
Why?
|
| Point Mutation | 1 | 2018 | 88 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2017 | 66 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2001 | 562 | 0.040 |
Why?
|
| Phosphorylation | 1 | 2020 | 878 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 59 | 0.040 |
Why?
|
| California | 1 | 2018 | 436 | 0.040 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 131 | 0.040 |
Why?
|
| Rats, Wistar | 2 | 2011 | 202 | 0.040 |
Why?
|
| Education, Medical | 1 | 2018 | 97 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 555 | 0.040 |
Why?
|
| Genotype | 1 | 2018 | 641 | 0.040 |
Why?
|
| Dioxins | 1 | 2015 | 8 | 0.030 |
Why?
|
| Body Weight | 1 | 2017 | 404 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 78 | 0.030 |
Why?
|
| Education, Graduate | 1 | 2014 | 27 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 65 | 0.030 |
Why?
|
| Faculty, Medical | 1 | 2014 | 63 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2015 | 118 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 520 | 0.030 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2014 | 75 | 0.030 |
Why?
|
| Glucose | 1 | 2015 | 217 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 355 | 0.030 |
Why?
|
| Aconitine | 1 | 2011 | 2 | 0.030 |
Why?
|
| GABA Agents | 1 | 2011 | 2 | 0.030 |
Why?
|
| 4-Aminopyridine | 1 | 2011 | 7 | 0.030 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2011 | 6 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2011 | 10 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2011 | 17 | 0.030 |
Why?
|
| Potassium Channel Blockers | 1 | 2011 | 30 | 0.020 |
Why?
|
| Conotoxins | 1 | 2011 | 18 | 0.020 |
Why?
|
| Acetylcholine | 1 | 2011 | 68 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 323 | 0.020 |
Why?
|
| Protein Binding | 1 | 2011 | 913 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2002 | 130 | 0.010 |
Why?
|
| Ion Channel Gating | 1 | 2002 | 81 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2002 | 214 | 0.010 |
Why?
|